Contrast induced nephropathy medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Management of CIN routinely includes the avoidance of substances that are toxic to the kidneys. Dialysis is rarely required for [[AKI]] following contrast administration, but occasionally patients will require dialysis in the acute setting. The indications for dialysis are the same as in other forms of [[AKI]]. | |||
==References== | ==References== | ||
Revision as of 19:32, 11 September 2013
|
Contrast Induced Nephropathy Microchapters |
|
Differentiating Contrast induced nephropathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Contrast induced nephropathy medical therapy On the Web |
|
American Roentgen Ray Society Images of Contrast induced nephropathy medical therapy |
|
Directions to Hospitals Treating Contrast induced nephropathy |
|
Risk calculators and risk factors for Contrast induced nephropathy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Management of CIN routinely includes the avoidance of substances that are toxic to the kidneys. Dialysis is rarely required for AKI following contrast administration, but occasionally patients will require dialysis in the acute setting. The indications for dialysis are the same as in other forms of AKI.